Literature DB >> 19756851

Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings.

Sabina Giusti1, Davide Caramella, Elena Fruzzetti, Michele Lazzereschi, Adele Tognetti, Carlo Bartolozzi.   

Abstract

The purpose of this study was to retrospectively characterize benign and malignant prostate peripheral zone tissue by using endorectal MRI and 3D ¹H MRS. Fifty-two men with untreated biopsy-proven prostate cancer underwent combined endorectal MRI and MRSI. Whole-mount step-section histopathologic analysis constituted the reference standard. Biopsy correctly detected 74 locations; MRI correctly detected 72 locations; MRS correctly detected 72 locations; MRI + MRS correctly detected 78 locations. Cohen's test showed that biopsy had a lower degree of agreement with histology than MRI + MRS combined. The ratio of [(Cho + Cr)]/Cit correlates with the pathologic Gleason score. The addition of 3D¹H MRSI to MRI can improve diagnosis of prostate cancer contributing indirectly to improve local staging. In addition, the correlation between metabolic 3D¹H MRSI data with pathological Gleason grade may offer a non-invasive means to better predict prostate cancer aggressiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756851     DOI: 10.1007/s00261-009-9577-9

Source DB:  PubMed          Journal:  Abdom Imaging        ISSN: 0942-8925


  6 in total

Review 1.  Metabolic Imaging in Humans.

Authors:  Taylor L Fuss; Leo L Cheng
Journal:  Top Magn Reson Imaging       Date:  2016-10

2.  Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.

Authors:  Liang Wang
Journal:  World J Radiol       Date:  2009-12-31

Review 3.  Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.

Authors:  John V Hegde; Robert V Mulkern; Lawrence P Panych; Fiona M Fennessy; Andriy Fedorov; Stephan E Maier; Clare M C Tempany
Journal:  J Magn Reson Imaging       Date:  2013-05       Impact factor: 4.813

4.  Recent advances in magnetic resonance imaging of prostate cancer.

Authors:  Nathan Lawrentschuk; Uri Lindner
Journal:  F1000 Med Rep       Date:  2010-12-08

5.  Impact of the integration of proton magnetic resonance imaging spectroscopy to PI-RADS 2 for prediction of high grade and high stage prostate cancer.

Authors:  Michael S Leapman; Zhen J Wang; Spencer C Behr; John Kurhanewicz; Ronald J Zagoria; Peter R Carroll; Antonio C Westphalen
Journal:  Radiol Bras       Date:  2017 Sep-Oct

Review 6.  Developments in proton MR spectroscopic imaging of prostate cancer.

Authors:  Angeliki Stamatelatou; Tom W J Scheenen; Arend Heerschap
Journal:  MAGMA       Date:  2022-04-20       Impact factor: 2.533

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.